ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Niederhuber To Stay at NCI While Obama Makes NIH Plans

January 23, 2009

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Bill Would Improve Quality Of Care, Close Gaps in Services, Supporters Say. Sen. Arlen Specter to NIH Advocates: “Be More Politically Active;” Asks NCI For “A Winning Strategy.”

May 26, 2006

NIH Clinical Center Offers Sabbatical In Clinical Research Management

October 1, 2010

In Brief: Albert and Mary Lasker Foundation announce 2014 award winners

September 12, 2014